Holen Sie sich die Stockscreener-App
13.02
2.12%
0.27
Handel nachbörslich:
13.05
0.03
+0.23%
Schlusskurs vom Vortag:
$12.75
Offen:
$12.82
24-Stunden-Volumen:
1.78M
Relative Volume:
1.21
Marktkapitalisierung:
$724.96M
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-4.8401
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
-31.51%
1M Leistung:
-31.62%
6M Leistung:
-43.86%
1J Leistung:
-31.00%
1-Tages-Spanne:
$12.62
$13.05
1-Wochen-Bereich:
$10.96
$19.54
52-Wochen-Spanne:
$10.96
$34.84
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Vergleichen Sie CDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
13.02 | 1.06B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
What drives CareDx Inc stock priceRecord-setting profit potential - Autocar Professional
CareDx Inc Stock Analysis and ForecastPowerful profit generation - jammulinksnews.com
CareDx (NASDAQ:CDNA shareholders incur further losses as stock declines 33% this week, taking five-year losses to 60% - Yahoo Finance
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains? - Nasdaq
How to Take Advantage of moves in (CDNA) - news.stocktradersdaily.com
Buying the Dips in 2 Diagnostic Names After 'Significant Overreactions' - TheStreet Pro
What analysts say about CareDx Inc stockSuperior stock selection - jammulinksnews.com
Is CareDx Inc a good long term investmentExceptional growth trajectory - Autocar Professional
CareDx's Strategic Positioning in the Evolving Transplant Diagnostics Market: Reinforcing Revenue Stability and Long-Term Growth - AInvest
CareDx rebounds as draft LCD suggests no change in coverage - MSN
CareDx Rebounds After Draft LCD Suggests No Change in Coverage - AInvest
CareDx (CDNA): Analyst Rating Maintained, Price Target Lowered | - GuruFocus
CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection - Business Wire
Caredx Inc stock hits 52-week low at 14.07 USD By Investing.com - Investing.com South Africa
Caredx Inc stock hits 52-week low at 14.07 USD - Investing.com
CareDx Plummets 38% Intraday: What's Behind the Record Collapse? - AInvest
Why CareDx Inc stock attracts strong analyst attentionExpert Trading Flow - Newser
How CareDx Inc stock performs during market volatilityTargeted 200 Percent Gain - Newser
What makes CareDx Inc stock price move sharplyFast Moving Stock Alerts - Newser
CareDx Q2 2024 presentation: Revenue jumps 31%, company raises full-year guidance - Investing.com Australia
CareDx Q2 2024 presentation: Revenue jumps 31%, company raises full-year guidance By Investing.com - Investing.com South Africa
Learn to Evaluate (CDNA) using the Charts - news.stocktradersdaily.com
Strong week for CareDx (NASDAQ:CDNA) shareholders doesn't alleviate pain of five-year loss - simplywall.st
CareDx (CDNA) Stock Upgraded to Buy by Nephron Research | CDNA S - GuruFocus
CareDx’s HeartCare Study: A Game Changer in Transplant Monitoring? - The Globe and Mail
CareDx’s ALAMO Study: A Game Changer in Lung Transplant Surveillance? - TipRanks
CareDx’s HeartCare Study: A Game-Changer in Transplant Surveillance? - TipRanks
CareDx ($CDNA) Is Paying a $20.25M Settlement to Investors — Here’s How to Get Your Share - TradingView
Rhumbline Advisers Trims Stock Position in CareDx, Inc. (NASDAQ:CDNA) - Defense World
GAMMA Investing LLC Acquires 43,694 Shares of CareDx, Inc. (NASDAQ:CDNA) - Defense World
Wealth Enhancement Advisory Services LLC Invests $210,000 in CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx (NASDAQ:CDNA) Stock Crosses Above 50-Day Moving Average After Insider Selling - Defense World
CareDx and $CDNA Investors Finalise Settlement Agreement — Here’s How to Get Your Share - TradingView
CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road Ahead - Seeking Alpha
A Closer Look at Caredx Inc (CDNA) Stock Gains - investchronicle.com
CareDx, Inc. (CDNA) Stock Analysis: Unveiling a 55% Potential Upside with Strong Analyst Support - DirectorsTalk Interviews
CareDx Stockholders Approve Key Proposals at Annual Meeting - TipRanks
(CDNA) Technical Data - news.stocktradersdaily.com
CareDx at Goldman Sachs Conference: Strategic Growth and Expansion By Investing.com - Investing.com Canada
Transcript : CareDx, Inc Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener
Bank of America Corp DE Sells 300,261 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):